BMCM
ABVX

Burns Matteson Capital Management’s Abivax ABVX Stock Holding History

Burns Matteson Capital Management’s Portfolio ABVX Stock Details ABVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-8,500
Closed -$579K – 191
2026
Q1 		$579K Buy
+8,500
New +$1.01M 0.21% 84

Other funds holding ABVX

Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
NFT
Nan Fung Trinity Central, Hong Kong, Hong Kong $1.01B AUM 64.38% 1-Year Est. Return
ACM
ACT Capital Management Wayne, Pennsylvania $153M AUM
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
AP
Andera Partners Paris $206M AUM
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.94% 1-Year Est. Return
HP
HealthInvest Partners Stockholm, Sweden $372M AUM 59.89% 1-Year Est. Return
SCS
Syquant Capital SAS Paris, France $447M AUM 13.04% 1-Year Est. Return

Burns Matteson Capital Management's ABVX Position: Q2 2026 in Review

Burns Matteson Capital Management reduced its Abivax (ABVX) stake by 2.7% in Q2 2026, selling an estimated $16.3K and leaving 5,105 shares worth $680K. The position accounts for 0.21% of the portfolio, ranked #76.

Burns Matteson Capital Management first reported a position in ABVX in Q4 2025 and has held it in 3 quarters since. 71 funds tracked by Wall St. Rank hold ABVX as of Q2 2026.

  • Burns Matteson Capital Management held 5,105 shares of Abivax worth $680K as of Q2 2026.
  • Burns Matteson Capital Management sold 144 Abivax shares in Q2 2026, an estimated $16.3K.
  • Abivax made up 0.21% of Burns Matteson Capital Management's portfolio in Q2 2026, its #76 holding.
  • Burns Matteson Capital Management first reported a position in Abivax in Q4 2025 and has held it in 3 quarters since.
  • 71 funds tracked by Wall St. Rank held Abivax as of Q2 2026.

Based on Burns Matteson Capital Management's 13F filing for Q2 2026, filed 17 Jul 2026.